- Home
- PROK vs TCBX Comparison
PROK vs TCBX Comparison
Compare PROK & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | TCBX |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 481.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PROK | TCBX |
|---|---|---|
| Price | $2.48 | $37.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $7.40 | ★ $41.67 |
| AVG Volume (30 Days) | ★ 1.3M | 80.0K |
| Earning Date | 11-10-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.90 |
| EPS | N/A | ★ 3.56 |
| Revenue | $744,000.00 | ★ $192,224,000.00 |
| Revenue This Year | $956.51 | $24.66 |
| Revenue Next Year | N/A | $17.56 |
| P/E Ratio | ★ N/A | $10.79 |
| Revenue Growth | N/A | ★ 20.96 |
| 52 Week Low | $0.46 | $25.17 |
| 52 Week High | $7.13 | $41.70 |
Technical Indicators
Market Signals| Indicator | PROK | TCBX |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 42.20 |
| Support Level | $2.10 | $36.81 |
| Resistance Level | $2.29 | $38.94 |
| Average True Range (ATR) | 0.17 | 1.15 |
| MACD | 0.01 | -0.29 |
| Stochastic Oscillator | 76.53 | 19.33 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.